Biotech

All Articles

Lundbeck indicators $2.5 B check for Longboard and its epilepsy med

.After snooping smash hit possibility in Longboard Pharmaceuticals' epilepsy med, brain disease-focu...

Lilly decides on UK for 1st Portal Lab in Europe

.Eli Lilly's Entrance Labs is actually going worldwide, along with the U.K. federal government intro...

Jasper dials up dosage after hives responses reoccur quickly

.Jasper Rehab has actually stated full actions in 10 of the 12 severe hives clients who got the high...

Transgene's viral cancer cells vaccination flunks midphase test

.Transgene's restorative injection prospect TG4001 has actually failed a stage 2 strong cyst test. B...

Upstream swells IPO to $255M as it specifies along with CAMP4

.Upstream Biography possesses inflamed its IPO to $255 thousand as the business participates in CAMP...

Sanofi flunks MS study, giving another strike to Denali treaty

.Sanofi has actually quit a phase 2 ordeal of Denali Therapeutics-partnered oditrasertib in multiple...

Turnstone gives up 60%, agitates C-suite to stretch out cash money

.Turnstone Biologics is actually lowering its head count through 60% as well as shaking up its own C...

Gilead surrenders on $15M MASH bet after reviewing preclinical data

.In a year that has actually observed an authorization and a range of readouts for metabolic dysfunc...

Texas biotech axes cancer cells pact, pins wishes on weight problems

.Alaunos Therapies is axing a contract with Precigen, giving up licensing legal rights to an individ...

Capricor portions extra records for DMD treatment after launching BLA

.Capricor Therapies is taking a victory lap for their stage 2 Duchenne muscle dystrophy (DMD) trial....